Patent 7064190 was granted and assigned to Roche on June, 2006 by the United States Patent and Trademark Office.
The invention concerns autoreactive peptides, peptide-MHC complexes, T cell subpopulations that react thereto as well as diagnostic and therapeutic applications of these compounds.